<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40868251</PMID><DateCompleted><Year>2025</Year><Month>09</Month><Day>14</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>14</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2227-9059</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>8</Issue><PubDate><Year>2025</Year><Month>Aug</Month><Day>17</Day></PubDate></JournalIssue><Title>Biomedicines</Title><ISOAbbreviation>Biomedicines</ISOAbbreviation></Journal><ArticleTitle>A Combined Approach to the Prevention of Postoperative Atrial Fibrillation in Cardiac Surgery.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1999</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/biomedicines13081999</ELocationID><Abstract><AbstractText><b>Background:</b> Postoperative atrial fibrillation (POAF) is a common complication after cardiac surgery with cardiopulmonary bypass (CPB) affecting between 5% and 40% of patients, which leads to hemodynamic instability, an increased risk of thromboembolism, decompensated heart failure, prolonged hospitalization, and higher treatment costs. Currently, there are no universally accepted guidelines for preventing POAF. <b>Methods:</b> A single-center, prospective, randomized controlled trial, "The Effect of Colchicine on the Occurrence of Atrial Fibrillation after Cardiac Surgery" (CAFE), ClinicalTrials.gov ID: NCT06798714, was conducted. The study included 140 patients with coronary artery disease randomized into two groups of 70 patients each. Group 1 (control group) received standard postoperative care. Group 2 (intervention group) received colchicine (Colchicum-Dispert at a dose of 500 mcg 4 h before coronary artery bypass grafting (CABG) with CPB and at a dose of 500 mcg twice daily for 10 days postoperatively) and underwent intraoperative pericardial fenestration using an original technique. <b>Results:</b> Perioperative colchicine administration combined with intraoperative pericardial fenestration reduced POAF incidence to 2.9% compared to the control group with POAF incidence of 12.9% (<i>p</i> &lt; 0.05). This management strategy was not associated with an increased incidence of infectious complications, gastrointestinal disorders, or elevated levels of alanine aminotransferase, aspartate aminotransferase, or creatinine. <b>Conclusions:</b> Perioperative colchicine administration combined with pericardial fenestration during CABG with CPB is associated with a reduced POAF incidence, good tolerability, and does not contribute to an increased incidence of infectious complications or impaired liver and renal function.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Diakova</LastName><ForeName>Mariia L</ForeName><Initials>ML</Initials><Identifier Source="ORCID">0000-0001-9353-7234</Identifier><AffiliationInfo><Affiliation>Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, 634012 Tomsk, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuznetsov</LastName><ForeName>Mikhail S</ForeName><Initials>MS</Initials><Identifier Source="ORCID">0000-0002-1975-043X</Identifier><AffiliationInfo><Affiliation>Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, 634012 Tomsk, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vechersky</LastName><ForeName>Yuri Yu</ForeName><Initials>YY</Initials><Identifier Source="ORCID">0000-0002-7175-4526</Identifier><AffiliationInfo><Affiliation>Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, 634012 Tomsk, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Elena B</ForeName><Initials>EB</Initials><Identifier Source="ORCID">0009-0001-5610-3506</Identifier><AffiliationInfo><Affiliation>Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, 634012 Tomsk, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zyryanov</LastName><ForeName>Stepan V</ForeName><Initials>SV</Initials><Identifier Source="ORCID">0000-0002-1352-6517</Identifier><AffiliationInfo><Affiliation>Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, 634012 Tomsk, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petlin</LastName><ForeName>Konstantin A</ForeName><Initials>KA</Initials><Identifier Source="ORCID">0000-0001-9906-9945</Identifier><AffiliationInfo><Affiliation>Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, 634012 Tomsk, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kozlov</LastName><ForeName>Boris N</ForeName><Initials>BN</Initials><Identifier Source="ORCID">0000-0002-0217-7737</Identifier><AffiliationInfo><Affiliation>Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, 634012 Tomsk, Russia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT06798714</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><GrantID>theme no. 123051500130-9</GrantID><Agency>the Ministry of Science and Higher Education of the Russian Federation in the framework of the state assignment for applied scientific research</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>08</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Biomedicines</MedlineTA><NlmUniqueID>101691304</NlmUniqueID><ISSNLinking>2227-9059</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cardiac surgery</Keyword><Keyword MajorTopicYN="N">cardiopulmonary bypass</Keyword><Keyword MajorTopicYN="N">colchicine</Keyword><Keyword MajorTopicYN="N">pericardial drainage</Keyword><Keyword MajorTopicYN="N">pericardial fenestration</Keyword><Keyword MajorTopicYN="N">postoperative atrial fibrillation</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>7</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>8</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>8</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>30</Day><Hour>4</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>8</Month><Day>30</Day><Hour>4</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>8</Month><Day>28</Day><Hour>1</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>8</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40868251</ArticleId><ArticleId IdType="pmc">PMC12383744</ArticleId><ArticleId IdType="doi">10.3390/biomedicines13081999</ArticleId><ArticleId IdType="pii">biomedicines13081999</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Dobrev D., Aguilar M., Heijman J., Guichard J.B., Nattel S. Postoperative atrial fibrillation: Mechanisms, manifestations and management. Nat. Rev. Cardiol. 2019;16:417&#x2013;436. doi: 10.1038/s41569-019-0166-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-019-0166-5</ArticleId><ArticleId IdType="pubmed">30792496</ArticleId></ArticleIdList></Reference><Reference><Citation>Agarwal S., Beard C.W., Khosla J., Clifton S., Anwaar M.F., Ghani A., Farhat K., Pyrpyris N., Momani J., Munir M.B., et al. Safety and efficacy of colchicine for the prevention of post-operative atrial fibrillation in patients undergoing cardiac surgery: A meta-analysis of randomized controlled trials. Europace. 2023;25:euad169. doi: 10.1093/europace/euad169.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/europace/euad169</ArticleId><ArticleId IdType="pmc">PMC10318383</ArticleId><ArticleId IdType="pubmed">37341446</ArticleId></ArticleIdList></Reference><Reference><Citation>Lennerz C., Barman M., Tantawy M., Sopher M., Whittaker P. Colchicine for primary prevention of atrial fibrillation after open-heart surgery: Systematic review and meta-analysis. Int. J. Cardiol. 2017;249:127&#x2013;137. doi: 10.1016/j.ijcard.2017.08.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2017.08.039</ArticleId><ArticleId IdType="pubmed">28918897</ArticleId></ArticleIdList></Reference><Reference><Citation>Malektojari A., Javidfar Z., Ghazizadeh S., Lahuti S., Shokraei R., Zeinaee M., Badele A., Mirzadeh R., Ashrafi M., Afra F., et al. Effectiveness of anti-inflammatory agents to prevent atrial fibrillation after cardiac surgery: A systematic review and network meta-analysis. CJC Open. 2025;7:35&#x2013;45. doi: 10.1016/j.cjco.2024.10.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cjco.2024.10.008</ArticleId><ArticleId IdType="pmc">PMC11763850</ArticleId><ArticleId IdType="pubmed">39872654</ArticleId></ArticleIdList></Reference><Reference><Citation>Hogue C.W., Jr., Creswell L.L., Gutterman D.D., Fleisher L.A., American College of Chest Physicians Epidemiology, mechanisms, and risks: American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery. Chest. 2005;128:9&#x2013;16. doi: 10.1378/chest.128.2_suppl.9S.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.128.2_suppl.9S</ArticleId><ArticleId IdType="pubmed">16167659</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivera F.B., Whoy Cha S., Aparece J.P., Jariyatamkitti S., Mamas M.A. Efficacy and Safety of Colchicine for the Prevention of Postoperative Atrial Fibrillation Among Patients Undergoing Major Cardiothoracic Surgery: A Meta-analysis and Meta-regression of Randomized Controlled Trials. J. Cardiovasc. Pharmacol. 2024;83:265&#x2013;270. doi: 10.1097/FJC.0000000000001533.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/FJC.0000000000001533</ArticleId><ArticleId IdType="pubmed">38181213</ArticleId></ArticleIdList></Reference><Reference><Citation>Salih M., Smer A., Charnigo R., Ayan M., Darrat Y.H., Traina M., Morales G.X., DiBiase L., Natale A., Elayi C.S. Colchicine for prevention of post-cardiac procedure atrial fibrillation: Meta-analysis of randomized controlled trials. Int. J. Cardiol. 2017;243:258&#x2013;262. doi: 10.1016/j.ijcard.2017.04.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2017.04.022</ArticleId><ArticleId IdType="pubmed">28747027</ArticleId></ArticleIdList></Reference><Reference><Citation>Attia A., Muthukumarasamy K.M., Al-U&#x2019;Datt D.G.F., Hiram R. Relevance of Targeting Oxidative Stress, Inflammatory, and Pro-Resolution Mechanisms in the Prevention and Management of Postoperative Atrial Fibrillation. Antioxidants. 2025;14:414. doi: 10.3390/antiox14040414.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox14040414</ArticleId><ArticleId IdType="pmc">PMC12023940</ArticleId><ArticleId IdType="pubmed">40298654</ArticleId></ArticleIdList></Reference><Reference><Citation>Diakova M.L., Shipulin V.M., Svirko Y.S., Gusakova A.M., Podoksenov Y.K., Kamenshchikov N.O., Kozlov B.N. Systemic inflammatory response in cardiac surgery: Possibilities of using colchicine. Kardiologiia. 2023;63:39&#x2013;46. doi: 10.18087/cardio.2023.7.n2229.</Citation><ArticleIdList><ArticleId IdType="doi">10.18087/cardio.2023.7.n2229</ArticleId><ArticleId IdType="pubmed">37522826</ArticleId></ArticleIdList></Reference><Reference><Citation>Nomani H., Mohammadpour A.H., Moallem S.M.H., Sahebkar A. Anti-inflammatory drugs in the prevention of post-operative atrial fibrillation: A literature review. Inflammopharmacology. 2020;28:111&#x2013;129. doi: 10.1007/s10787-019-00653-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10787-019-00653-x</ArticleId><ArticleId IdType="pubmed">31673892</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong T., Pu L., Ma Y.F., Zhu Y.L., Li H., Cui X., Li Y.X. Posterior pericardiotomy to prevent new-onset atrial fibrillation after coronary artery bypass grafting: A systematic review and meta-analysis of 10 randomized controlled trials. J. Cardiothorac. Surg. 2021;16:233. doi: 10.1186/s13019-021-01611-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13019-021-01611-x</ArticleId><ArticleId IdType="pmc">PMC8364072</ArticleId><ArticleId IdType="pubmed">34391454</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuznetsov M.S., Petlin K.A., Pryakhin A.S., Nasraschvili G.G., Panfilov D.S., Kozhanov R.S., Schipulin V.M., Kozlov B.N. Wound drainage in cardiac surgery. Russ. J. Cardiol. Cardiovasc. Surg. 2022;15:412&#x2013;416. doi: 10.17116/kardio202215041412. (In Russian)</Citation><ArticleIdList><ArticleId IdType="doi">10.17116/kardio202215041412</ArticleId></ArticleIdList></Reference><Reference><Citation>Burstein B., Nattel S. Atrial fibrosis: Mechanisms and clinical relevance in atrial fibrillation. J. Am. Coll. Cardiol. 2008;51:802&#x2013;809. doi: 10.1016/j.jacc.2007.09.064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2007.09.064</ArticleId><ArticleId IdType="pubmed">18294563</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwasaki Y.K., Nishida K., Kato T., Nattel S. Atrial fibrillation pathophysiology: Implications for management. Circulation. 2011;124:2264&#x2013;2274. doi: 10.1161/CIRCULATIONAHA.111.019893.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.111.019893</ArticleId><ArticleId IdType="pubmed">22083148</ArticleId></ArticleIdList></Reference><Reference><Citation>Goette A., Kalman J.M., Aguinaga L., Akar J., Cabrera J.A., Chen S.A., Chugh S.S., Corradi D., D&#x2019;Avila A., Dobrev D., et al. EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication. EP Eur. 2016;18:1455&#x2013;1490. doi: 10.1093/europace/euw161.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/europace/euw161</ArticleId><ArticleId IdType="pmc">PMC6392440</ArticleId><ArticleId IdType="pubmed">27402624</ArticleId></ArticleIdList></Reference><Reference><Citation>Imazio M., Brucato A., Ferrazzi P., Rovere M.E., Gandino A., Cemin R., Ferrua S., Belli R., Maestroni S., Simon C., et al. COPPS Investigators. Colchicine reduces postoperative atrial fibrillation: Results of the Colchicine for the Prevention of the Postpericardiotomy Syndrome (COPPS) atrial fibrillation substudy. Circulation. 2011;124:2290&#x2013;2295. doi: 10.1161/CIRCULATIONAHA.111.026153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.111.026153</ArticleId><ArticleId IdType="pubmed">22090167</ArticleId></ArticleIdList></Reference><Reference><Citation>Nidorf S.M., Fiolet A.T.L., Mosterd A., Eikelboom J.W., Schut A., Opstal T.S.J., The S.H.K., Xu X.F., Ireland M.A., Lenderink T., et al. LoDoCo2 Trial Investigators. Colchicine in Patients with Chronic Coronary Disease. N. Engl. J. Med. 2020;383:1838&#x2013;1847. doi: 10.1056/NEJMoa2021372.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2021372</ArticleId><ArticleId IdType="pubmed">32865380</ArticleId></ArticleIdList></Reference><Reference><Citation>Imazio M., Brucato A., Ferrazzi P., Pullara A., Adler Y., Barosi A., Caforio A.L., Cemin R., Chirillo F., Comoglio C., et al. Colchicine for prevention of postpericardiotomy syndrome and postoperative atrial fibrillation: The COPPS-2 randomized clinical trial. JAMA. 2014;312:1016&#x2013;1023. doi: 10.1001/jama.2014.11026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2014.11026</ArticleId><ArticleId IdType="pubmed">25172965</ArticleId></ArticleIdList></Reference><Reference><Citation>Shvartz V., Le T., Kryukov Y., Sokolskaya M., Ispiryan A., Khugaeva E., Yurkulieva G., Shvartz E., Petrosyan A., Bockeria L., et al. Colchicine for Prevention of Atrial Fibrillation after Cardiac Surgery in the Early Postoperative Period. J. Clin. Med. 2022;11:1387. doi: 10.3390/jcm11051387.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11051387</ArticleId><ArticleId IdType="pmc">PMC8911341</ArticleId><ArticleId IdType="pubmed">35268478</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao H., Chen Y., Mao M., Yang J., Chang J. A meta-analysis of colchicine in prevention of atrial fibrillation following cardiothoracic surgery or cardiac intervention. J. Cardiothorac. Surg. 2022;17:224. doi: 10.1186/s13019-022-01958-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13019-022-01958-9</ArticleId><ArticleId IdType="pmc">PMC9438305</ArticleId><ArticleId IdType="pubmed">36050741</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabbalat R.A., Hamad N.M., Alhaddad I.A., Hammoudeh A., Akasheh B.F., Khader Y. Effect of ColchiciNe on the InciDence of Atrial Fibrillation in Open Heart Surgery Patients: END-AF Trial. Am. Heart J. 2016;178:102&#x2013;107. doi: 10.1016/j.ahj.2016.05.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ahj.2016.05.006</ArticleId><ArticleId IdType="pubmed">27502857</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarpelon C.S., Netto M.C., Jorge J.C., Fabris C.C., Desengrini D., da Silva Jardim M., Silva D.G. Colchicine to reduce atrial fibrillation in the postoperative period of myocardial revascularization. Arq. Bras. Cardiol. 2016;107:4&#x2013;9. doi: 10.5935/abc.20160082.</Citation><ArticleIdList><ArticleId IdType="doi">10.5935/abc.20160082</ArticleId><ArticleId IdType="pmc">PMC4976950</ArticleId><ArticleId IdType="pubmed">27223641</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaudino M., Sanna T., Ballman K., Robinson N.R., Hameed I., Audisio K., Rahouma M., Di Franco A., Soletti G.J., Lau C., et al. Posterior left pericardiotomy for the prevention of atrial fibrillation after cardiac surgery: An adaptive, single-centre, single-blind, randomised, controlled trial. Lancet. 2021;398:2075&#x2013;2083. doi: 10.1016/S0140-6736(21)02490-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)02490-9</ArticleId><ArticleId IdType="pubmed">34788640</ArticleId></ArticleIdList></Reference><Reference><Citation>Rathnayake A., Goh S., Fenton C., Fenton C., Hardikar A. Posterior pericardiotomy and the prevention of post-operative atrial fibrillation and cardiac tamponade in isolated coronary artery bypass grafting&#x2014;A retrospective analysis. J. Cardiothorac. Surg. 2024;19:263. doi: 10.1186/s13019-024-02569-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13019-024-02569-2</ArticleId><ArticleId IdType="pmc">PMC11040876</ArticleId><ArticleId IdType="pubmed">38659034</ArticleId></ArticleIdList></Reference><Reference><Citation>Vecchi&#xe9; A., Del Buono M., Chiabrando G.J., Dentali F., Abbate A., Bonaventura A. Interleukin-1 and the NLRP3 Inflammasome in Pericardial Disease. Curr. Cardiol. Rep. 2021;23:157. doi: 10.1007/s11886-021-01589-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11886-021-01589-x</ArticleId><ArticleId IdType="pmc">PMC8485973</ArticleId><ArticleId IdType="pubmed">34599390</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonaventura A., Vecchie A., Mauro A.G., Brucato A.L., Imazio M., Abbate A. An update on the pathophysiology of acute and recurrent pericarditis. Panminerva Med. 2020;63:249&#x2013;260. doi: 10.23736/S0031-0808.20.04205-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.23736/S0031-0808.20.04205-6</ArticleId><ArticleId IdType="pubmed">33337127</ArticleId></ArticleIdList></Reference><Reference><Citation>Mauro A.G., Bonaventura A., Vecchie A., Mezzaroma E., Carbone S., Narayan P., Potere N., Cannat&#xe0; A., Paolini J.F., Bussani R., et al. The role of NLRP3 inflammasome in pericarditis: Potential for therapeutic approaches. JACC Basic Transl. Sci. 2021;6:137&#x2013;150. doi: 10.1016/j.jacbts.2020.11.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacbts.2020.11.016</ArticleId><ArticleId IdType="pmc">PMC7907621</ArticleId><ArticleId IdType="pubmed">33665514</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao C., Veleva T., Scott L., Cao S., Li L., Chen G., Jeyabal P., Pan X., Alsina K.M., Abu-Taha I., et al. Enhanced cardiomyocyte NLRP3 inflammasome signaling promotes atrial fibrillation. Circulation. 2018;138:2227&#x2013;2242. doi: 10.1161/CIRCULATIONAHA.118.035202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.118.035202</ArticleId><ArticleId IdType="pmc">PMC6252285</ArticleId><ArticleId IdType="pubmed">29802206</ArticleId></ArticleIdList></Reference><Reference><Citation>Heijman J., Muna A.P., Veleva T., Molina C.E., Sutanto H., Tekook M., Wang Q., Abu-Taha I.H., Gorka M., K&#xfc;nzel S., et al. Atrial myocyte NLRP3/CaMKII nexus forms a substrate for postoperative atrial fibrillation. Circ. Res. 2020;127:1036&#x2013;1055. doi: 10.1161/CIRCRESAHA.120.316710.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.120.316710</ArticleId><ArticleId IdType="pmc">PMC7604886</ArticleId><ArticleId IdType="pubmed">32762493</ArticleId></ArticleIdList></Reference><Reference><Citation>Goette A., Corradi D., Dobrev D., Aguinaga L., Cabrera J., Chugh S.S., de Groot J.R., Soulat-Dufour L., Fenelon G., Hatem S.N., et al. Atrial cardiomyopathy revisited&#x2014;Evolution of a concept: A clinical consensus statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Society (HRS), the Asian Pacific Heart Rhythm Society (APHRS), and the Latin American Heart Rhythm Society (LAHRS) EP Eur. 2024;26:euae204. doi: 10.1093/europace/euae204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/europace/euae204</ArticleId><ArticleId IdType="pmc">PMC11431804</ArticleId><ArticleId IdType="pubmed">39077825</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>